Patent Term Extension Application for ICOTYDE® (icotrokinra), Patent No. 12,552,836 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-8227

Patent Term Extension Application for ICOTYDE® (icotrokinra), Patent No. 12,552,836

Documents

Comments

Description

OPEN

Comment Period OpensJul 30, 2026

Type	Title	Posted	Comments	Status
Other	Letter from U. S. Patent and Trademark Office to FDA CDER	Jul 30, 2026	--

CDER

Patent Term Extension Application for ICOTYDE®

Baker & Hostetler LLP

Janssen Biotech, Inc.

(icotrokinra)

Patent No. 12,552,836

OPEN